Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZURA Zura Bio

交易中 12-15 13:17:00 EST

4.09

+0.07

+1.74%

最高4.09	最低3.88	成交量15.50万
今开4.06	昨收4.02	日振幅5.22%
总市值2.66亿	流通市值1.01亿	总股本6,502万
成交额61.93万	换手率0.63%	流通股本2,468万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZURA","market":"US","secType":"STK","nameCN":"Zura Bio","latestPrice":4.09,"timestamp":1765822601240,"preClose":4.02,"halted":0,"volume":155020,"delay":0,"floatShares":24675000,"shares":65023300,"eps":-0.670864,"marketStatus":"交易中","change":0.07,"latestTime":"12-15 13:17:00 EST","open":4.06,"high":4.09,"low":3.88,"amount":619345.794276,"amplitude":0.052239,"askPrice":4.09,"askSize":500,"bidPrice":4.08,"bidSize":114,"shortable":3,"etf":0,"ttmEps":-0.670864,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.02,"postHourTrading":{"tag":"盘后","latestPrice":3.7686,"preClose":4.02,"latestTime":"18:35 EST","volume":8513,"amount":32572.5826,"timestamp":1765582538822},"volumeRatio":0.600424,"impliedVol":2.1392,"impliedVolPercentile":0.776},"requestUrl":"/m/hq/s/ZURA","defaultTab":"news","newsList":[{"id":"2588270351","title":"Zura Bio Limited盘中异动 快速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588270351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588270351?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:34","pubTimestamp":1764599645,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时34分，Zura Bio Limited股票出现异动，股价快速下挫5.69%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Q32 Bio Inc.、Kala Bio, Inc.、Maia Biotechnology, Inc.涨幅较大，Q32 Bio Inc.、Kala Bio, Inc.、Aditxt, Inc.较为活跃，换手率分别为510.54%、507.40%、48.28%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Q32 Bio Inc.、Kala Bio, Inc.，振幅分别为101.36%、31.05%、18.63%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012234059524dbbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512012234059524dbbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2584523869","title":"Zura Bio Limited盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584523869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584523869?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:57","pubTimestamp":1763477878,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时57分，Zura Bio Limited股票出现异动，股价快速下跌5.26%。截至发稿，该股报3.78美元/股，成交量3.2416万股，换手率0.05%，振幅2.76%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.35%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118225759a4aa917e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118225759a4aa917e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"1114353463","title":"Zura Bio有限公司：预计现有现金及现金等价物足以支持到2027年的计划运营","url":"https://stock-news.laohu8.com/highlight/detail?id=1114353463","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114353463?lang=zh_cn&edition=full","pubTime":"2025-11-13 19:38","pubTimestamp":1763033896,"startTime":"0","endTime":"0","summary":"Zura Bio有限公司：预计现有现金及现金等价物足以支持到2027年的计划运营","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2583367539","title":"Zura Bio Limited盘中异动 股价大涨5.20%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583367539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583367539?lang=zh_cn&edition=full","pubTime":"2025-11-13 04:53","pubTimestamp":1762980781,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日04时53分，Zura Bio Limited股票出现波动，股价大幅拉升5.20%。截至发稿，该股报4.65美元/股，成交量69.5972万股，换手率1.07%，振幅9.05%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.42%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304530195009a9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111304530195009a9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2582165361","title":"Zura Bio Limited盘中异动 股价大涨5.31%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582165361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582165361?lang=zh_cn&edition=full","pubTime":"2025-11-11 01:07","pubTimestamp":1762794439,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日01时07分，Zura Bio Limited股票出现异动，股价快速拉升5.31%。截至发稿，该股报3.87美元/股，成交量9.8894万股，换手率0.15%，振幅4.63%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.51%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111010719a6eff731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111010719a6eff731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2574488368","title":"Zura Bio Limited盘中异动 早盘快速下挫5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574488368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574488368?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:36","pubTimestamp":1760107013,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时36分，Zura Bio Limited股票出现波动，股价急速下挫5.17%。截至发稿，该股报4.28美元/股，成交量34.1644万股，换手率0.53%，振幅6.43%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.35%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102236539726b3a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102236539726b3a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2561411432","title":"Zura Bio Limited盘中异动 早盘大幅上涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561411432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561411432?lang=zh_cn&edition=full","pubTime":"2025-08-21 21:42","pubTimestamp":1755783748,"startTime":"0","endTime":"0","summary":"北京时间2025年08月21日21时42分，Zura Bio Limited股票出现异动，股价快速上涨5.71%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.10%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821214228a6f38115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250821214228a6f38115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2558668786","title":"Zura Bio Limited盘中异动 股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558668786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558668786?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:32","pubTimestamp":1754919138,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时32分，Zura Bio Limited股票出现波动，股价急速拉升5.63%。截至发稿，该股报1.50美元/股，成交量4.7266万股，换手率0.08%，振幅0.00%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.46%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213219a6dfb871&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811213219a6dfb871&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2557056783","title":"Zura Bio Limited盘中异动 早盘快速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557056783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557056783?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:29","pubTimestamp":1754490581,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时29分，Zura Bio Limited股票出现波动，股价急速下挫5.13%。截至发稿，该股报1.49美元/股，成交量5.1798万股，换手率0.08%，振幅5.41%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.51%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622294194d392ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622294194d392ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2557470390","title":"Zura Bio Limited盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557470390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557470390?lang=zh_cn&edition=full","pubTime":"2025-08-05 22:05","pubTimestamp":1754402731,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日22时05分，Zura Bio Limited股票出现异动，股价快速拉升5.14%。截至发稿，该股报1.54美元/股，成交量10.8354万股，换手率0.18%，振幅5.82%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为2.83%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522053194d16fa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080522053194d16fa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2556927848","title":"Zura Bio Limited盘中异动 下午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556927848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556927848?lang=zh_cn&edition=full","pubTime":"2025-08-02 01:11","pubTimestamp":1754068266,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日01时11分，Zura Bio Limited股票出现波动，股价急速拉升5.00%。截至发稿，该股报1.47美元/股，成交量20.0436万股，换手率0.32%，振幅8.57%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.24%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802011106972d5b55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802011106972d5b55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2555052609","title":"Zura Bio Limited盘中异动 股价大跌5.43%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052609","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052609?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:54","pubTimestamp":1753797286,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时54分，Zura Bio Limited股票出现波动，股价大幅跳水5.43%。截至发稿，该股报1.53美元/股，成交量5.4816万股，换手率0.09%，振幅4.81%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.08%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544697258e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921544697258e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2552487611","title":"Zura Bio Limited盘中异动 早盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552487611?lang=zh_cn&edition=full","pubTime":"2025-07-17 22:09","pubTimestamp":1752761348,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日22时09分，Zura Bio Limited股票出现波动，股价大幅上涨5.43%。截至发稿，该股报1.36美元/股，成交量43.0438万股，换手率0.70%，振幅3.39%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.42%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220908a45150a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717220908a45150a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2550968160","title":"Zura Bio Limited盘中异动 股价大跌5.04%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550968160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550968160?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:13","pubTimestamp":1752250398,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时13分，Zura Bio Limited股票出现异动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量9.8682万股，换手率0.16%，振幅4.32%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.26%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001318a44539ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712001318a44539ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2550625923","title":"Zura Bio Limited盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625923?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154277,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Zura Bio Limited股票出现波动，股价快速拉升5.13%。截至发稿，该股报1.42美元/股，成交量1.1955万股，换手率0.02%，振幅2.22%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.14%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213117a442b790&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213117a442b790&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2550527188","title":"Zura Bio Limited盘中异动 下午盘股价大涨5.00%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527188","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550527188?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:21","pubTimestamp":1751998909,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时21分，Zura Bio Limited股票出现波动，股价快速上涨5.00%。截至发稿，该股报1.16美元/股，成交量21.2763万股，换手率0.34%，振幅6.30%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为1.18%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709022149a69da3a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709022149a69da3a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2549530494","title":"Zura Bio Limited盘中异动 早盘股价大涨5.31%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549530494?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:32","pubTimestamp":1751895148,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时32分，Zura Bio Limited股票出现波动，股价快速拉升5.31%。截至发稿，该股报1.19美元/股，成交量2.8235万股，换手率0.05%，振幅0.00%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.09%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213228a43bf699&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213228a43bf699&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZURA"],"gpt_icon":0},{"id":"2548915816","title":"Zura Bio Limited盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548915816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548915816?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:32","pubTimestamp":1751463175,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时32分，Zura Bio Limited股票出现异动，股价急速拉升5.24%。截至发稿，该股报1.11美元/股，成交量9926股，换手率0.02%，振幅3.81%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.22%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022132559533fd78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507022132559533fd78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2547097035","title":"Zura Bio Limited盘中异动 早盘快速上涨7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097035?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Zura Bio Limited股票出现波动，股价急速拉升7.62%。截至发稿，该股报1.13美元/股，成交量1.0915万股，换手率0.02%，振幅0.00%。Zura Bio Limited股票所在的生物技术行业中，整体涨幅为0.06%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213103a4c6c3da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213103a4c6c3da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0},{"id":"2546264417","title":"Zura Bio Limited盘中异动 下午盘股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546264417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546264417?lang=zh_cn&edition=full","pubTime":"2025-06-28 02:30","pubTimestamp":1751049015,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日02时30分，Zura Bio Limited股票出现波动，股价快速跳水5.22%。截至发稿，该股报1.09美元/股，成交量16.2412万股，换手率0.26%，振幅6.52%。Zura Bio Limited股票所在的生物技术行业中，整体跌幅为0.60%。Zura Bio Limited公司简介：Zura Bio Ltd 是一家临床阶段的多资产免疫学公司，致力于开发针对自身免疫和炎症性疾病的新型双通路抗体。该公司正在开发 tibulizumab 和 torudokimab 的治疗适应症组合，旨在证明它们在自身免疫和炎症性疾病中的疗效、安全性和给药便利性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628023015a4c1b8a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628023015a4c1b8a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZURA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zurabio.com","stockEarnings":[{"period":"1week","weight":0.0749},{"period":"1month","weight":-0.1317},{"period":"3month","weight":1.01},{"period":"6month","weight":2.35},{"period":"1year","weight":0.8273},{"period":"ytd","weight":0.608}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zura Bio Limited成立于2022年1月。该公司是一家临床阶段、多资产免疫学公司，致力于为一系列未满足需求的自身免疫和炎症性疾病开发新型双通路抗体。凭借团队的丰富经验，公司识别相关疾病，并在这些疾病中开发差异化资产。公司战略重点是利用双通路生物的力量，为自身免疫性和炎症性疾病患者提供更广泛、更深层次的临床获益。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.158249},{"month":2,"riseRate":0.75,"avgChangeRate":0.007816},{"month":3,"riseRate":0.5,"avgChangeRate":0.020185},{"month":4,"riseRate":0.75,"avgChangeRate":0.079189},{"month":5,"riseRate":0.25,"avgChangeRate":-0.072869},{"month":6,"riseRate":0.75,"avgChangeRate":0.041052},{"month":7,"riseRate":0.75,"avgChangeRate":0.075734},{"month":8,"riseRate":0.75,"avgChangeRate":0.126932},{"month":9,"riseRate":0.5,"avgChangeRate":0.266974},{"month":10,"riseRate":0.6,"avgChangeRate":-0.062262},{"month":11,"riseRate":0.6,"avgChangeRate":-0.053189},{"month":12,"riseRate":0.4,"avgChangeRate":-0.033731}],"exchange":"NASDAQ","name":"Zura Bio","nameEN":"Zura Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zura Bio(ZURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zura Bio,ZURA,Zura Bio股票,Zura Bio股票老虎,Zura Bio股票老虎国际,Zura Bio行情,Zura Bio股票行情,Zura Bio股价,Zura Bio股市,Zura Bio股票价格,Zura Bio股票交易,Zura Bio股票购买,Zura Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zura Bio(ZURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zura Bio(ZURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}